Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Disease
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Ischemic Heart Disease
- Sponsor
- Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
- Enrollment
- 697
- Locations
- 16
- Primary Endpoint
- Diagnosis of IHD at Invasive Coronary Angiography and FFR Measurement
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
Main purpose of the study:
To comparatively assess the diagnostic performance of non invasive anatomical and functional imaging modalities to detect significant obstructive coronary artery disease as demonstrated at invasive coronary angiography and functional evaluation of coronary lesions (fractional flow reserve).
Detailed Description
Objectives of the study 1. To test the accuracy of anatomical and functional non-invasive cardiac imaging in the diagnosis of IHD. To this purpose the "anatomical" information provided by CTA is obtained in every patient together with the "functional" information provided by stress radionuclide cardiac imaging (SPECT or PET), to assess myocardial perfusion, and/or by stress MRI or ECHO imaging to assess myocardial contraction. Non-invasive results are tested against invasive reference standards. The latter consists of invasive coronary angiography integrated by invasive measurement of fractional flow reserve (to assess the hemodynamic relevance of intermediate coronary stenoses). 2. To test the accuracy of integrated models, including clinical variables, risk factors and circulating biomarkers, to predict significant obstructive coronary artery disease in patients with chronic angina-like symptoms. To correlate biohumoral profiles with the coronary anatomical-functional phenotype as obtained by non invasive imaging in the same patients. To reach these goals the clinical characterization of patients (collected before non-invasive imaging) and the laboratory characterization (that includes novel biomarkers of cardiovascular risk) are compared with patient characterization derived from non invasive "anatomic-functional" imaging and with invasive diagnosis of significantly obstructive coronary disease. 3. To develop an advanced clinical and imaging reporting tool in cardiology. An informatics platform is developed to synthetically and clearly present the integrated clinical and imaging diagnostic profile of individual patients. A multimodal imaging reporting tool is developed including tools for "image fusion" of different imaging modalities (CT, SPECT, PET, MRI). 4. To define the most cost-effective work-up for the diagnosis and characterization of IHD. To this purpose the costs and the procedural risks (including radiation exposure) of non-invasive and invasive diagnostic procedures are prospectively collected. Cost-benefit and cost-effectiveness analyses is conducted alongside the EVINCI-study clinical trial.
Investigators
Danilo Neglia
MD
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
Eligibility Criteria
Inclusion Criteria
- •Patients with intermediate (\>20%, \<90%) risk of IHD based on age,gender,symptoms and exercise stress test results
Exclusion Criteria
- •Age \< 30 Yrs or \> 75 yrs
- •Pregnancy (suspected or ascertained)
- •LV Dysfunction (LVEF \< 35% by Echo or other method)
- •Low (\< =20%) or high (\>=90%) probability of CAD
- •Acute Coronary Syndrome
- •Prolonged (\> 20 minutes) chest pain
- •De novo or accelerated angina
- •Hemodynamic or electrical instability
- •Recent ST-T segment or T wave changes of ischemic nature
- •Acute myocardial infarction with or without ST segment elevation
Outcomes
Primary Outcomes
Diagnosis of IHD at Invasive Coronary Angiography and FFR Measurement
Time Frame: 3 months from enrollment
The outcome measure is the number of participants who received the diagnosis of IHD at invasive coronary angiography coupled with FFR measurements (in case of intermediate coronary lesions).
Secondary Outcomes
- Cost-benefit and Cost-effectiveness Analysis(3 months)